Dissemin is shutting down on January 1st, 2025

Published in

Wiley, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 4(38), p. e25-e28

DOI: 10.1002/phar.2100

Links

Tools

Export citation

Search in Google Scholar

Valsartan Effective for Malignant Hypertension after Aortic Dissection with Renal Artery Involvement

Journal article published in 2018 by Christopher J. Michaud ORCID, Brian Trethowan
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

When aortic dissections extend to the renal arteries, reductions in renal blood flow can cause marked increases in renin production. The resultant rise in angiotensin II can lead to difficult‐to‐control blood pressure, despite normal postdissection antihypertensive agents. We highlight a case of a postdissection patient with malignant hypertension refractory to eight different enteral antihypertensives. Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers had been held due to postoperative acute kidney injury. A single dose of valsartan, administered on day 12, produced a marked drop in blood pressure, alleviation of encephalopathy, and allowed for cancellation of a planned tracheostomy. A serum renin level was found to be 50 times the normal upper limit. In patients with aortic dissection and renal artery involvement, angiotensin‐modifying agents may warrant earlier administration to combat this unique cause of hypertension.